FundedIQ
Pharmaceutical Manufacturing

Lenz Therapeutics

LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.

LENZ-Tx.com Del Mar, United States 11-50 employees
Total raised
$49.0M
Rounds
1
Latest
Series Unknown
Nov 2022

LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.

Lenz Therapeutics has raised $49.0M across 1 round. Its most recent round was a Series Unknown of $49.0M in Nov 2022. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Nov 22, 2022
Series Unknown
$49.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Lenz Therapeutics is featured in

Similar companies

India Globalization Capital

India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and China. In India, the Company is engaged in supplying and trading iron ore and in leasing construction equipment, and to a lesser extent constructing roads, highways and supply rock aggregate. In June 2014, the Company acquired 51% interest of Golden Gate Electronics Limited.

Series Unknown $230k
Juniper Biosciences

Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.

Seed $40.0M
Corsair Pharma

Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.

Series B $23.0M
Egetis Therapeutics AB

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.

Series Unknown $38.3M
D-Wave Quantum

D-Wave provides development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society.

Series Unknown $1.6M
Beeline Medicines

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

Series A $126M
Xellar Biosystems

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Series A $29.5M
Kite Realty Group Trust

Kite Realty Group Trust is a real estate investment trust that focuses on developing, constructing, acquiring, owning, and operating shopping centers in growth markets in the US. The company owns a portfolio of retail properties, commercial properties, and land for potential future development. Their strategy is to maximize cash flow from existing properties, complete development projects, and identify new growth opportunities through tenant relationships and acquisitions. They primarily invest in shopping centers but may also pursue commercial development opportunities in markets where they already operate.

Series Unknown $300M
Premier Lacrosse League

Premier Lacrosse League features top athletes in the rapidly expanding sport of lacrosse, leading the way in shaping a fan-centric future for the game. They also offer a variety of sports apparel for sale on their website.

Series E $100M
Eos

Eos creates cutting-edge and affordable energy storage solutions for the electric utility, solar, and commercial/industrial sectors. By using their battery technology, renewables can be dependable and cost-effective, meeting market expectations and sustainability goals.

Series Unknown $75.0M
Ognomy Sleep

Ognomy is transforming the $10B+ sleep health market by delivering fast, convenient, insured virtual care for obstructive sleep apnea (OSA). With a 50-state sleep medicine clinician network and in-network coverage for 200M+ lives, Ognomy makes high-quality sleep apnea care accessible at national scale. Our proprietary cloud platform, enhanced by AI-driven workflow tools, streamlines operations and empowers clinicians — enabling faster diagnosis and better patient outcomes while maintaining a patient-first approach. With 25,000+ patients cared for and an 81 NPS, our results speak for themselves.

Series A $20.0M
Tenon Medical

Tenon Medical, a biotech firm specializing in enhancing surgical solutions for the SI joint, was established in 2012 in Morgan Hill, California.

Series Unknown $4.2M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.